Department of Pediatric Endocrinology, Faculty of Medicine, Ataturk University, Erzurum, Turkey,
Eur Arch Otorhinolaryngol. 2014 Apr;271(4):689-93. doi: 10.1007/s00405-013-2455-7. Epub 2013 Mar 30.
The aims of this study were to evaluate serum vitamin D levels in cases of recurrent otitis media and investigate the effect of vitamin D therapy on the risk of re-occurrence of the disease. This prospective study was performed by comparing serum vitamin D levels in children with recurrent otitis media and healthy children. Eighty-four children between 1 and 5 years of age and diagnosed with recurrent otitis media were enrolled as the study group. One hundred-and-eight healthy children with similar demographic characteristics were enrolled as the control group. Patients were divided into groups according to their serum 25(OH) vitamin D levels. In patients with low initial serum vitamin D levels, vitamin D therapy was administered in addition to conventional treatment for otitis media. Mean serum 25(OH) vitamin D level in the study group was 11.4 ± 9.8 ng/mL Serum 25(OH) vitamin D levels were below 20 ng/mL in 69 % (n = 58) of cases in this group. In the control group, mean serum 25(OH) vitamin D level was 29.2 ± 13.9 ng/mL and was below 20 ng/mL in 30 % (n = 32) of cases. Comparison of serum 25(OH) vitamin D levels and PTH in the study and control groups revealed a statistically significant difference (p < 0.05). Treatment was initiated in cases diagnosed with vitamin D deficiency, and patients were followed up in due course. The only episodes detected over the course of 1-year follow-up were one attack in five patients and two attacks in two. We believe that co-administration of supplementary vitamin D together with conventional treatments is appropriate in the management of upper respiratory infections such as otitis media.
本研究旨在评估复发性中耳炎患者的血清维生素 D 水平,并探讨维生素 D 治疗对疾病复发风险的影响。本前瞻性研究通过比较复发性中耳炎患儿和健康儿童的血清维生素 D 水平来进行。共纳入 84 名 1 至 5 岁、诊断为复发性中耳炎的儿童作为研究组,纳入 108 名具有相似人口统计学特征的健康儿童作为对照组。根据血清 25(OH)维生素 D 水平将患者分为不同组。在初始血清维生素 D 水平较低的患者中,除了常规中耳炎治疗外,还给予维生素 D 治疗。研究组患者平均血清 25(OH)维生素 D 水平为 11.4 ± 9.8ng/ml,69%(n=58)的患者血清 25(OH)维生素 D 水平低于 20ng/ml。在对照组中,平均血清 25(OH)维生素 D 水平为 29.2 ± 13.9ng/ml,30%(n=32)的患者血清 25(OH)维生素 D 水平低于 20ng/ml。研究组和对照组的血清 25(OH)维生素 D 水平和 PTH 比较,差异有统计学意义(p<0.05)。对诊断为维生素 D 缺乏症的患者进行治疗,并在适当的时候进行随访。在 1 年的随访过程中,仅发现 5 例患者有 1 次发作,2 例患者有 2 次发作。我们认为,在上呼吸道感染(如中耳炎)的治疗中,联合补充维生素 D 和常规治疗是合适的。